PL2403512T3 - Kompozycje polimerowego mircenu - Google Patents

Kompozycje polimerowego mircenu

Info

Publication number: PL2403512T3
Authority: PL; Poland
Prior art keywords: compositions; polymeric myrcene; myrcene; polymeric
Prior art date: 2009-03-04

Application number

PL10710912T

Other languages

English (en)

Inventor

Zadik Hazan

Shimon Amselem

Original Assignee

Regenera Pharma Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-03-04

Filing date

2010-03-04

Publication date

2019-10-31

2010-03-04 Application filed by Regenera Pharma Ltd filed Critical Regenera Pharma Ltd

2019-10-31 Publication of PL2403512T3 publication Critical patent/PL2403512T3/pl

Links

UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 title 2
VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Natural Medicines & Medicinal Plants (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Botany (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Hematology (AREA)
Diabetes (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)

PL10710912T 2009-03-04 2010-03-04 Kompozycje polimerowego mircenu PL2403512T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US15721609P	2009-03-04	2009-03-04
EP10710912.6A EP2403512B1 (en)	2009-03-04	2010-03-04	Compositions of polymeric myrcene
PCT/IL2010/000184 WO2010100651A2 (en)	2009-03-04	2010-03-04	Compositions of polymeric myrcene

Publications (1)

Publication Number	Publication Date
PL2403512T3 true PL2403512T3 (pl)	2019-10-31

Family

ID=42536397

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL10710912T PL2403512T3 (pl)	2009-03-04	2010-03-04	Kompozycje polimerowego mircenu

Country Status (15)

Country	Link
US (4)	US8722105B2 (pl)
EP (2)	EP3578191A1 (pl)
CN (2)	CN105147759A (pl)
AU (1)	AU2010220057C1 (pl)
BR (1)	BRPI1013222B8 (pl)
CA (1)	CA2754565C (pl)
DK (1)	DK2403512T3 (pl)
EA (2)	EA201492273A1 (pl)
ES (1)	ES2739033T3 (pl)
HK (1)	HK1218710A1 (pl)
HU (1)	HUE045444T2 (pl)
IL (2)	IL214923A (pl)
PL (1)	PL2403512T3 (pl)
TR (1)	TR201911270T4 (pl)
WO (1)	WO2010100651A2 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8722105B2 (en)	2009-03-04	2014-05-13	Zadik Hazan	Compositions of polymeric myrcene
CA2754564C (en)	2009-03-04	2017-09-12	Regenera Pharma Ltd.	Therapeutic uses of mastic gum fractions
ES2562807T3 (es) *	2009-10-28	2016-03-08	Regenera Pharma Ltd.	Monoterpenos poliméricos para tratar la función neurológica alterada
BR112013005300B1 (pt)	2010-09-07	2021-11-09	Regenera Pharma Ltd	Composição que compreende extratos ácidos de goma mástique
US8979797B2 (en) *	2010-12-16	2015-03-17	Ams Research Corporation	High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
WO2013011511A1 (en)	2011-07-18	2013-01-24	Mor Research Applications Ltd.	A device for adjusting the intraocular pressure
CN102526163A (zh) *	2011-12-27	2012-07-04	浙江景岳堂药业有限公司	一种用于风痛灵中乳香和没药的提取方法
US20150246087A1 (en) *	2012-06-11	2015-09-03	Regenera Pharma Ltd.	Extracts and therapeutic uses thereof
US9458362B2 (en)	2014-04-02	2016-10-04	Kraton Polymers U.S. Llc	Adhesive compositions containing a block copolymer with polymyrcene
US10053603B2 (en)	2014-04-02	2018-08-21	Kraton Polymers U.S. Llc	Block copolymers containing a copolymer myrcene block
IL237621A0 (en) *	2015-03-08	2015-06-30	Regenera Pharma Ltd	Use of isolated fractions of the gum goddess to treat optic neuropathy
WO2017051423A1 (en) *	2015-09-24	2017-03-30	Regenera Pharma Ltd.	Compositions comprising triterpenoids
US20180256603A1 (en)	2015-09-24	2018-09-13	Regenera Pharma Ltd.	Compositions comprising triterpenoids
US10548917B2 (en) *	2016-05-23	2020-02-04	Kaeco Group Inc.	Supplement for the prevention and treatment of gastrointestinal distress in horses and other species
US11439676B2 (en)	2018-10-16	2022-09-13	Kaeco Group, Inc.	Method for prevention or treating gastrointestinal distress in humans using mastic gum compositions
WO2018047175A1 (en)	2016-09-08	2018-03-15	Regenera Pharma Ltd.	Compositions comprising triterpenoids and uses thereof for treating optic neuropathy
BR112019004500A2 (pt) *	2016-09-08	2019-05-28	Regenera Pharma Ltd	composições compreendendo extratos ácidos de goma de mastique e utilizações das mesmas para o tratamento de neuropatias óticas
IT201700016726A1 (it) *	2017-02-15	2018-08-15	Phytoitalia Srl	Frazioni arricchite in terpeni esenti da politerpeni estratte dal mastice di chios, dispositivi cosmetici, nutraceutici e medici, e composizioni farmaceutiche che le contengono
WO2019170239A1 (en)	2018-03-08	2019-09-12	Phytoitalia Srl	Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them
EP3873508A4 (en) *	2018-11-01	2022-05-18	Yeditepe Universitesi	PHARMACEUTICALS FOR THE TREATMENT OF PSORIASIS AND METHOD OF PRODUCTION THEREOF
WO2026068507A1 (en) *	2024-09-25	2026-04-02	Givaudan Sa	Emulsion comprising aqueous phase, hop oil, emulsifier and polymeric terpene

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4374957A (en)	1981-10-29	1983-02-22	Michigan Molecular Institute	Triblock polymers of a monovinyl aromatic compound and myrcene
US4564718A (en)	1984-08-14	1986-01-14	The University Of Manchester Institute Of Science And Technology	Functionally terminated polymers from terpene monomers and their applications
US4713243A (en)	1986-06-16	1987-12-15	Johnson & Johnson Products, Inc.	Bioadhesive extruded film for intra-oral drug delivery and process
JPS63179908A (ja) *	1987-01-22	1988-07-23	Japan Synthetic Rubber Co Ltd	ミルセン重合体およびその製造方法
DE3820218A1 (de)	1988-06-14	1989-12-28	Osama L M Dr Med Dr Rer N Omer	Phytotherapeutikum zur behandlung von depressivem syndrom
US8178516B2 (en)	1992-06-30	2012-05-15	Sylvan Labs, LLC	Compositions and method for treatment of chronic inflammatory diseases
US5506406A (en)	1993-05-17	1996-04-09	Atomic Energy Corporation Of South Africa Ltd.	Method and apparatus for determining the concentration of a heavy element in a rock face
US5759569A (en)	1995-01-10	1998-06-02	The Procter & Gamble Company	Biodegradable articles made from certain trans-polymers and blends thereof with other biodegradable components
US5714007A (en)	1995-06-06	1998-02-03	David Sarnoff Research Center, Inc.	Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
GR950100243A (el)	1995-06-28	1997-02-28	�. ��- �. �� .�.�.	Χρησιμοποιηση της φυσικης μαστιχας χιου η του εξαγομενου εξ'αυτης φυσικου μαστιχελαιου η συνθετικων παραγωγων του για την παρασεκυη οδοντοκρεμας, οδοντικου διαλυματος, αποσμητικου στοματος, αντιηλιακων, προιοντων μαλλιων, καθως και καλλυντικων προιοντων.
JPH10130254A (ja) *	1996-11-01	1998-05-19	Jumoku Seiri Kinousei Butsushitsu Gijutsu Kenkyu Kumiai	ジヒドロクマリン系化合物およびエストロゲン作用剤
DE19646392A1 (de)	1996-11-11	1998-05-14	Lohmann Therapie Syst Lts	Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
GR1003541B (el)	1999-05-11	2001-03-07		Αντιμικροβιακη και αντιμυκητιακη δραση του εξαγομενου απο τα κλαδια, φυλλα και καρπο της μαστιχας χιου -pistacia lentiscus var chia-, μαστιχελαιου, για χρηση σε καλλυντικες, φαρμακευτικες και παραφαρμακευτικεσς εφαρμογες καθως και στην παραγωγη οδοντοτσι
GR1003550B (el)	1999-09-22	2001-03-13		Σταθερο παρασκευασμα ισοεξυλοναφθαζαρινων με πεντα- και τετρα-κυκλικα τριτερπενια, συστατικα φυτικων ελαιορητινων και κομμεων
US6623728B2 (en)	2000-06-30	2003-09-23	Unilever Home & Personal Care Usa Division Of Conopco, Inc.	Cosmetic skin care compositions and containing gum mastic
US7056491B2 (en)	2000-11-08	2006-06-06	Wisconsin Alumni Research Foundation	Monoterpenes and sesquiterpenes as chemotherapeutic and radiation sensitizers and immunomodulators
GR1003868B (el)	2001-02-06	2002-04-19	Lavipharm S.A.	Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους
IL156976A0 (en)	2001-02-13	2004-02-08	Yissum Res Dev Co	Carotenoid-loaded liposomes
US6534548B1 (en)	2001-10-02	2003-03-18	Kimberly-Clark Worldwide, Inc.	Isoprenoid compositions for the inhibition of exoprotein production from gram positive bacteria
ATE441423T1 (de)	2002-05-01	2009-09-15	Lavipharm Sa	Verwendung von mastix und dessen ätherischen ílen zur verhinderung oder bekämpfung von mikrobieller infektionen
JP2004083443A (ja)	2002-08-23	2004-03-18	Hideji Watanabe	マスティックを用いた歯周病予防・治療用組成物及び歯周病予防・治療方法
CA2510860C (en)	2002-12-20	2012-10-09	Exxonmobil Chemical Patents Inc.	Polymerization process utilizing hydrofluorocarbons as diluents
US7332554B2 (en)	2002-12-20	2008-02-19	Exxonmobil Chemical Patents Inc.	Polymers with new sequence distributions
US20050074509A1 (en)	2003-10-02	2005-04-07	Data Medica Padova S.P.A.	Cancer treatment using natural plant products or essential oils extracted from some pistacia species or components
US20070219141A1 (en)	2003-12-08	2007-09-20	David Jones	Plant Materials Extraction Method
EP1721914B1 (en) *	2004-03-04	2010-11-17	Riken	Isotactic 3,4-isoprene polymer
WO2005112967A2 (en) *	2004-05-19	2005-12-01	Balfour Marketing Corp.	Anticancer activity of chios mastic gum
CA2572870A1 (en)	2004-07-06	2006-01-12	Transpharma Medical Ltd.	Delivery system for transdermal immunization
WO2006020246A1 (en)	2004-07-23	2006-02-23	Tsung-Chung Lin	Anti-hypersensitive inflammation and anti-allergy activities of zingiber zerumbet (l.) smith
EP1817941A4 (en)	2004-11-13	2009-11-11	Metaproteomics Llc	CYCLOOXYGENASE-2 INHIBITION COMPOSITIONS
US20070036873A1 (en)	2005-07-27	2007-02-15	Shibnath Ghosal	Method of treatment or management of stress
US20070148187A1 (en)	2005-12-27	2007-06-28	Intact Enterprises, Inc.	Mastic gum composition for use as a dietary supplement in humans and animals
AR060847A1 (es)	2007-05-03	2008-07-16	Spannagel Lucia Antonia	Formulacion a base de calendula, aloe y centella.
CA2754564C (en)	2009-03-04	2017-09-12	Regenera Pharma Ltd.	Therapeutic uses of mastic gum fractions
US8722105B2 (en)	2009-03-04	2014-05-13	Zadik Hazan	Compositions of polymeric myrcene

2010
- 2010-03-04 US US13/254,380 patent/US8722105B2/en active Active
- 2010-03-04 TR TR2019/11270T patent/TR201911270T4/tr unknown
- 2010-03-04 PL PL10710912T patent/PL2403512T3/pl unknown
- 2010-03-04 HU HUE10710912A patent/HUE045444T2/hu unknown
- 2010-03-04 AU AU2010220057A patent/AU2010220057C1/en not_active Ceased
- 2010-03-04 DK DK10710912.6T patent/DK2403512T3/da active
- 2010-03-04 CN CN201510616984.0A patent/CN105147759A/zh active Pending
- 2010-03-04 EP EP19158751.8A patent/EP3578191A1/en active Pending
- 2010-03-04 EA EA201492273A patent/EA201492273A1/ru unknown
- 2010-03-04 EA EA201190170A patent/EA021833B1/ru not_active IP Right Cessation
- 2010-03-04 EP EP10710912.6A patent/EP2403512B1/en active Active
- 2010-03-04 CA CA2754565A patent/CA2754565C/en active Active
- 2010-03-04 BR BRPI1013222A patent/BRPI1013222B8/pt not_active IP Right Cessation
- 2010-03-04 ES ES10710912T patent/ES2739033T3/es active Active
- 2010-03-04 CN CN201080018570.3A patent/CN102413834B/zh not_active Expired - Fee Related
- 2010-03-04 WO PCT/IL2010/000184 patent/WO2010100651A2/en not_active Ceased
2011
- 2011-09-01 IL IL214923A patent/IL214923A/en active IP Right Grant
2014
- 2014-03-26 US US14/226,293 patent/US9655938B2/en not_active Expired - Fee Related
2016
- 2016-06-10 HK HK16106667.1A patent/HK1218710A1/zh unknown
- 2016-09-26 IL IL248056A patent/IL248056B/en active IP Right Grant
2017
- 2017-04-13 US US15/486,964 patent/US10307449B2/en active Active
2019
- 2019-04-23 US US16/391,881 patent/US10806763B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2754565A1 (en)	2010-09-10
TR201911270T4 (tr)	2019-08-21
WO2010100651A2 (en)	2010-09-10
US8722105B2 (en)	2014-05-13
WO2010100651A3 (en)	2010-10-28
AU2010220057B2 (en)	2015-04-02
CN105147759A (zh)	2015-12-16
WO2010100651A4 (en)	2010-12-23
US9655938B2 (en)	2017-05-23
HK1218710A1 (zh)	2017-03-10
EP2403512B1 (en)	2019-05-15
ES2739033T3 (es)	2020-01-28
AU2010220057C1 (en)	2015-10-29
CN102413834A (zh)	2012-04-11
CN102413834B (zh)	2016-11-09
DK2403512T3 (da)	2019-07-22
AU2010220057A1 (en)	2011-10-13
US20170252387A1 (en)	2017-09-07
US20190255132A1 (en)	2019-08-22
EP2403512A2 (en)	2012-01-11
EA021833B1 (ru)	2015-09-30
US20140294928A1 (en)	2014-10-02
IL214923A0 (en)	2011-11-30
BRPI1013222B8 (pt)	2021-05-25
EP3578191A1 (en)	2019-12-11
US10806763B2 (en)	2020-10-20
BRPI1013222B1 (pt)	2021-03-16
US10307449B2 (en)	2019-06-04
BRPI1013222A2 (pt)	2017-09-26
US20120039992A1 (en)	2012-02-16
IL248056B (en)	2019-07-31
CA2754565C (en)	2020-12-29
EA201492273A1 (ru)	2015-04-30
IL248056A0 (en)	2016-11-30
EA201190170A1 (ru)	2013-01-30
HUE045444T2 (hu)	2019-12-30
IL214923A (en)	2016-10-31

Publication	Publication Date	Title
IL248056A0 (en)	2016-11-30	Compounds of polymeric myrcene
ZA201109176B (en)	2013-02-27	Homeglobin compositions
IL217949A0 (en)	2012-03-29	Pesticdal compositions
GB0906515D0 (en)	2009-05-20	Fungical compositions
IL217881A0 (en)	2012-03-29	Polymer compositions
HUE038234T2 (hu)	2018-10-29	Bendamusztin és ciklopoliszacharid kompozíciók
GB0910046D0 (en)	2009-07-22	Novel compositions
GB0908129D0 (en)	2009-06-24	Composition
IL218741A0 (en)	2012-06-28	Sanitizing compositions
ZA201109312B (en)	2013-02-27	Compositions
PL2516478T3 (pl)	2014-11-28	Modyfikowane kompozycje polimerowe
PL2516474T3 (pl)	2014-01-31	Modyfikowane kompozycje polimerowe
PL2226355T3 (pl)	2012-11-30	Kompozycje poliolefinowe sieciowane wilgocią
GB0910045D0 (en)	2009-07-22	Novel compositions
GB0901966D0 (en)	2009-03-11	Composition
GB0908642D0 (en)	2009-06-24	Composition
GB0906779D0 (en)	2009-06-03	Composition
GB0904941D0 (en)	2009-05-06	Composition
GB0905165D0 (en)	2009-05-06	Compositions
GB0906548D0 (en)	2009-05-20	Composition
GB0904942D0 (en)	2009-05-06	Composition
ZA201301490B (en)	2014-04-30	Fragranced spoap compositions
GB0903688D0 (en)	2009-04-15	Composition
GB0902959D0 (en)	2009-04-08	Composition
GB0902917D0 (en)	2009-04-08	Composition